[HTML][HTML] Quantitative magnetic resonance spectroscopy of depression: The value of short-term metabolite changes in predicting treatment response

R Wang, Y Shen, G Li, R Du, A Peng - Frontiers in Neuroscience, 2022 - frontiersin.org
Background Although various prediction models of the antidepressant response have been
established, the results have not been effectively applied to heterogeneous depression …

[HTML][HTML] Metabolomics-based discrimination of patients with remitted depression from healthy controls using 1H-NMR spectroscopy

CI Hung, G Lin, MH Chiang, CY Chiu - Scientific Reports, 2021 - nature.com
The aim of the study was to investigate differences in metabolic profiles between patients
with major depressive disorder (MDD) with full remission (FR) and healthy controls (HCs). A …

Hippocampal and parahippocampal volume and function predict antidepressant response in patients with major depression: A multimodal neuroimaging study

M Paolini, Y Harrington, F Colombo… - Journal of …, 2023 - journals.sagepub.com
Background: For many patients with major depressive disorder (MDD) adequate treatment
remains elusive. Neuroimaging techniques received attention for their potential use in …

[HTML][HTML] A comprehensive regional neurochemical theory in depression: a protocol for the systematic review and meta-analysis of 1H-MRS studies in major depressive …

T Drago, PW O'Regan, I Welaratne, S Rooney… - Systematic …, 2018 - Springer
Background Magnetic resonance spectroscopy (MRS) is a non-invasive analytical technique
that investigates the presence and concentrations of brain metabolites. In the context of …

Hippocampal neurometabolite changes in depression treatment: a 1H magnetic resonance spectroscopy study

V Husarova, M Bittsansky, I Ondrejka, V Kerna… - Psychiatry Research …, 2012 - Elsevier
Previous studies using magnetic resonance spectroscopy have related abnormalities in
hippocampal metabolism to depression. Current evidence is consistent with the conclusion …

[HTML][HTML] Neurometabolic characteristics in the anterior cingulate gyrus of Alzheimer's disease patients with depression: a 1H magnetic resonance spectroscopy study

Z Guo, J Zhang, X Liu, H Hou, Y Cao, F Wei, J Li… - BMC psychiatry, 2015 - Springer
Background Depression is a common comorbid psychiatric symptom in patients with
Alzheimer's disease (AD), and the prevalence of depression is higher among people with …

Altered neurometabolite levels in the brains of patients with depression: A systematic analysis of magnetic resonance spectroscopy studies

X Xie, Y Shi, L Ma, W Yang, J Pu, Y Shen, Y Liu… - Journal of Affective …, 2023 - Elsevier
Background Numerous magnetic resonance spectroscopy (MRS) studies have reported
metabolic abnormalities in the brains of patients with depression, although inconsistent …

Predicting neuroimaging biomarkers for antidepressant selection in early treatment of depression

L Xue, C Pei, X Wang, H Wang, S Tian… - Journal of Magnetic …, 2021 - Wiley Online Library
Background Due to the biological heterogeneity, 60%–70% of patients with major
depressive disorder (MDD) do not respond to or achieve remission from first‐line …

Proton MR spectroscopy of the hippocampus at 3 T in patients with unipolar major depressive disorder: correlates and predictors of treatment response

W Block, F Träber, O von Widdern… - International Journal …, 2009 - academic.oup.com
Various lines of research suggest that neurotrophic processes in the hippocampus are key
mechanisms in major depressive disorder and are of relevance for response to …

[HTML][HTML] A MRS study of metabolic alterations in the frontal white matter of major depressive disorder patients with the treatment of SSRIs

Y Zhang, Y Han, Y Wang, Y Zhang, L Li, E Jin, L Deng… - Bmc Psychiatry, 2015 - Springer
Background Proton magnetic resonance spectroscopy provides a non-invasive technology
to study brain metabolite levels in vivo, which can be used to measure biochemical …